| dc.creator |
Afsar, Rengin Elsurer |
|
| dc.creator |
AFŞAR, Barış |
|
| dc.date |
2023-11-01T00:00:00Z |
|
| dc.date.accessioned |
2025-02-25T10:21:08Z |
|
| dc.date.available |
2025-02-25T10:21:08Z |
|
| dc.identifier |
46b4a422-afa6-46e0-b191-16a45238fc04 |
|
| dc.identifier |
10.1111/micc.12832 |
|
| dc.identifier |
https://avesis.sdu.edu.tr/publication/details/46b4a422-afa6-46e0-b191-16a45238fc04/oai |
|
| dc.identifier.uri |
http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/99551 |
|
| dc.description |
Essential hypertension (HT) is the global health problem and is a major risk factor for the development of cardiovascular and kidney disease. High salt intake has been associated with HT and impaired kidney sodium excretion is considered to be a major mechanism for the development of HT. Although kidney has a very important role in regulation of BP, this traditional view of BP regulation was challenged by recent findings suggesting that nonosmotic tissue sodium deposition is very important for BP regulation. This new paradigm indicates that sodium can be stored and deposited nonosmotically in the interstitium without water retention and without increased BP. One of the major determinants of this deposition is glycosaminoglycans (GAGs). By binding to GAGs found in the endothelial surface layer (ESL) which contains glycocalyx, sodium is osmotically inactivated and not induce concurrent water retention. Thus, GAGs has important function for homeostatic BP and sodium regulation. In the current review, we summarized the role of GAGs in ESL and BP regulation. |
|
| dc.language |
eng |
|
| dc.rights |
info:eu-repo/semantics/closedAccess |
|
| dc.title |
The role of glycosaminoglycans in blood pressure regulation |
|
| dc.type |
info:eu-repo/semantics/article |
|